These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Disorders of lipid transport: relationship to abnormalities of apoproteins, enzymes and cellular receptors. Schonfeld G Prog Clin Biol Res; 1984; 147():375-402. PubMed ID: 6330755 [No Abstract] [Full Text] [Related]
23. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Attman PO; Alaupovic P; Tavella M; Knight-Gibson C Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654 [TBL] [Abstract][Full Text] [Related]
37. [Disorders of lipid metabolism in patients with nephrotic syndrome]. Zdrojewski Z Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):696-9. PubMed ID: 1492041 [No Abstract] [Full Text] [Related]
38. Evaluation of lipid and lipoprotein metabolism in rats as a model for studying age-related physiological changes. Lacko AG; Carlile S; Kudchodkar BJ J Gerontol; 1984 Sep; 39(5):513-20. PubMed ID: 6470439 [TBL] [Abstract][Full Text] [Related]
39. [Effects of dietary modification on the lipid metabolism in patients with chronic renal failure (author's transl)]. Tsukamoto Y; Okubo M; Marumo F; Yoneda T; Arai S; Homma Y; Nakamura H Nihon Jinzo Gakkai Shi; 1979 Feb; 21(2):111-21. PubMed ID: 470223 [No Abstract] [Full Text] [Related]
40. [The significance of hypolipemic drugs in the inhibition of progression of renal failure]. Chrzanowski W Pol Arch Med Wewn; 2002 Apr; 107(4):369-74. PubMed ID: 12189929 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]